Tag Archives: stake

AstraZeneca digs deeper into cancer therapy with a stake in Innate

AstraZeneca is plowing deeper into cancer immunotherapy through a wide-ranging deal with Innate Pharma, which includes the British group buying a 9.8 percent stake in the French biotech company. Tuesday’s agreement is a coup for Innate — run by former AstraZeneca executive Mondher Mahjoubi — which gains rights to sell AstraZeneca’s newly approved rare blood… Read More »